Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.35
-$0.015-0.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 386.65M | 372.23M | 394.58M | 476.17M | 526.35M |
| Total Depreciation and Amortization | 115.08M | 118.31M | 118.31M | 130.97M | 120.10M |
| Total Amortization of Deferred Charges | 13.90M | 11.07M | 11.07M | 4.73M | 8.48M |
| Total Other Non-Cash Items | 91.17M | 11.65M | 88.00M | -92.36M | 60.70M |
| Change in Net Operating Assets | -310.89M | -134.41M | -134.41M | -181.49M | -330.41M |
| Cash from Operations | 295.91M | 378.85M | 477.54M | 338.01M | 385.21M |
| Capital Expenditure | -147.07M | -143.59M | -156.86M | -178.17M | -198.56M |
| Sale of Property, Plant, and Equipment | 1.03M | 337.10K | 327.70K | 1.19M | 1.33M |
| Cash Acquisitions | 0.00 | -216.20K | -216.20K | -216.20K | -216.20K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -791.59M | -744.68M | -669.28M | -534.58M | -642.04M |
| Cash from Investing | -937.63M | -888.16M | -826.02M | -711.78M | -839.50M |
| Total Debt Issued | 11.09B | 9.01B | 9.95B | 10.67B | 10.19B |
| Total Debt Repaid | -9.09B | -8.53B | -8.65B | -9.74B | -10.31B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -245.78M | -312.85M | -312.03M | -220.78M | -220.67M |
| Other Financing Activities | 86.52M | -138.74M | -61.59M | 192.58M | -334.55M |
| Cash from Financing | 41.85M | -267.26M | -138.11M | -63.57M | -282.25M |
| Foreign Exchange rate Adjustments | 1.15M | 1.52M | 991.50K | 879.90K | 1.19M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -598.72M | -775.05M | -485.61M | -436.45M | -735.34M |